Medicine
Potassium chloride 600 mg extended-release capsule
Potassium chloride 600 mg extended-release capsule is a generic prescription medicine for oral use, made by 6 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at 20° to 25°C (68° to 77°F).
Key facts
- Active ingredient (INN)
- Potassium chloride
- Brand
- Sold under the generic name
- Strength
- 600 mg
- Dosage form
- Extended-release capsule
- Route
- Oral
- Packs
- 100 capsules, 500 capsules, 1000 capsules and 12 more
- Manufacturers
- Granules IndiaIndiaZydus LifesciencesIndiaSun Pharmaceutical IndustriesIndiaBryant Ranch PrepackPD-Rx PharmaceuticalsSolco Healthcare
- Origin register
- US FDA, United States
- Storage
- Store at 20° to 25°C (68° to 77°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- A12BA01 Potassium chloride
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 14 March 2019
- Identifiers
- RxCUI 312504, 315183DailyMed set ID 51586c47-1aff-4ce6-8030-89f9eb1bc9ac, 113c031c-6de3-4497-a57d-9740b1ce08ac, 4d90d03d-7f0e-4d49-9e80-628dbc7165c0 +4NDC 68382-853, 62207-914, 63304-078 +4Application ANDA208445, ANDA214686, ANDA208864 +1
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule, extended release in 1 bottle | 62207-914-43 | Granules IndiaIndia | 1 January 2023 |
| 500 capsule, extended release in 1 bottle | 62207-914-47 | Granules IndiaIndia | 1 January 2023 |
| 1000 capsule, extended release in 1 bottle | 62207-914-49 | Granules IndiaIndia | 1 January 2023 |
| 100 capsule, extended release in 1 bottle | 70010-147-01 | Granules IndiaIndia | 1 March 2021 |
| 100 capsule, extended release in 1 bottle | 63304-078-01 | Sun Pharmaceutical IndustriesIndia | 2 January 2020 |
| 100 capsule, extended release in 1 bottle | 68382-853-01 | Zydus LifesciencesIndia | 30 June 2019 |
| 500 capsule, extended release in 1 bottle | 68382-853-05 | Zydus LifesciencesIndia | 30 June 2019 |
| 1000 capsule, extended release in 1 bottle | 68382-853-10 | Zydus LifesciencesIndia | 30 June 2019 |
| 10 blister pack in 1 carton / 10 capsule, extended release in 1 blister pack | 68382-853-77 | Zydus LifesciencesIndia | 30 June 2019 |
| 100 capsule, extended release in 1 bottle | 43547-552-10 | Solco Healthcare | 30 April 2019 |
| 100 capsule, extended release in 1 bottle | 72162-1076-1 | Bryant Ranch Prepack | 5 April 2024 |
| 90 capsule, extended release in 1 bottle | 72162-1076-2 | Bryant Ranch Prepack | 5 April 2024 |
| 360 capsule, extended release in 1 bottle | 72162-1076-3 | Bryant Ranch Prepack | 5 April 2024 |
| 100 capsule, extended release in 1 bottle, plastic | 72789-056-01 | PD-Rx Pharmaceuticals | 25 February 2020 |
| 30 capsule, extended release in 1 bottle, plastic | 72789-056-30 | PD-Rx Pharmaceuticals | 14 July 2023 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 25 April 1975 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Potassium chloride
Clinical summary
Potassium chloride is an osmotic laxative indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. MedsAcross supplies Potassium chloride for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Potassium chlorideFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- KLOR-CON prescribing information (Upsher-Smith Laboratories) · U.S. National Library of Medicine, DailyMed
Need Potassium chloride 600 mg extended-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.